Home > Healthcare > Gastrointestinal Bleeding Treatment Market > Table of Contents

Gastrointestinal Bleeding Treatment Market – By Product (Endoscopic Hemostatic Devices [Mechanical, Thermal], Closure Devices), GI Tract Division (Upper, Lower), Onset (Acute, Chronic), End-use (Hospitals, ASCs) - Global Forecast (2024 – 2032)

  • Report ID: GMI8601
  • Published Date: Mar 2024
  • Report Format: PDF

Report Content

Chapter 1   Methodology & Scope

1.1    Market scope & definitions

1.2    Base estimates & calculations

1.3    Data collection

1.4    Forecast parameters

1.5    Data validation

1.6    Data sources

1.6.1    Primary

1.6.2    Secondary

1.6.2.1    Paid sources

1.6.2.2    Public sources

Chapter 2   Executive Summary

2.1    Industry 3600 synopsis

Chapter 3   Industry Insights

3.1    Industry ecosystem analysis

3.2    Industry impact forces

3.2.1    Growth drivers

3.2.1.1    Increasing incidence of gastrointestinal bleeding

3.2.1.2    Advancements in treatment technologies

3.2.1.3    Rising geriatric population

3.2.2    Industry pitfalls & challenges

3.2.2.1    High cost of treatment

3.2.2.2    Risk of complications

3.3    Growth potential analysis

3.4    Technology landscape

3.5    Regulatory landscape

3.6    Porter’s analysis

3.6.1    Supplier power

3.6.2    Buyer power

3.6.3    Threat of new entrants

3.6.4    Threat of substitutes

3.6.5    Industry rivalry

3.7    PESTEL analysis

Chapter 4   Competitive Landscape, 2023

4.1    Introduction

4.2    Company matrix analysis

4.3    Company market share analysis

4.4    Competitive positioning matrix

4.5    Strategic dashboard

Chapter 5   Market Estimates and Forecast, By Product, 2018 – 2032 ($ Mn)

5.1    Key trends

5.2    Endoscopic hemostatic devices

5.2.1    Endoscopic mechanical devices

5.2.2    Endoscopic thermal devices

5.3    Closure devices

5.4    Other products

Chapter 6   Market Estimates and Forecast, By GI Tract Division, 2018 – 2032 ($ Mn)

6.1    Key trends

6.2    Upper GI tract

6.3    Lower GI tract

Chapter 7   Market Estimates and Forecast, By Onset, 2018 – 2032 ($ Mn)

7.1    Key trends

7.2    Acute

7.3    Chronic

Chapter 8   Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)

8.1    Key trends

8.2    Hospitals

8.3    Ambulatory surgical centers (ASCs)

8.4    Other end-users

Chapter 9   Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)

9.1    Key trends, by region

9.2    North America

9.2.1    U.S.

9.2.2    Canada

9.3    Europe

9.3.1    Germany

9.3.2    UK

9.3.3    France

9.3.4    Spain

9.3.5    Italy

9.3.6    Rest of Europe

9.4    Asia Pacific

9.4.1    Japan

9.4.2    China

9.4.3    India

9.4.4    Australia

9.4.5    Rest of Asia Pacific

9.5    Latin America

9.5.1    Brazil

9.5.2    Mexico

9.5.3    Rest of Latin America

9.6    Middle East and Africa

9.6.1    South Africa

9.6.2    Saudi Arabia

9.6.3    Rest of Middle East and Africa

Chapter 10   Company Profiles

10.1    Boston Scientific Corporation

10.2    CONMED Corporation

10.3    Cook Group

10.4    ERBE Elektromedizin GmbH

10.5    Medtronic PLC

10.6    Olympus Corporation

10.7    Ovesco Endoscopy AG

10.8    Pfizer Inc.

10.9    STERIS PLC

10.10    US Medical Innovations
 

Authors: Mariam Faizullabhoy, Gauri Wani

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 10
  • Tables & Figures: 289
  • Countries covered: 19
  • Pages: 165
 Download Free Sample